Assyro AI

FDA Orange Book · active-ingredient family

Colchicine; probenecid

Colchicine; probenecid is approved as 1 brand and 10 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:COLBENEMID · NDA 012383

1

Brand (NDA)

10

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · tablet

ProductApplicantApplicationTEApproved
COLBENEMIDRLDMERCKNDA 012383Approved Prior to Jan 1, 1982

Generic (ANDA) products (10)

ProductApplicantApplicationTEApproved
PROBENECID AND COLCHICINERISINGANDA 217030ABOct 24, 2023
PROBENECID AND COLCHICINEINGENUS PHARMS LLCANDA 040618ABMay 13, 2008
COL-PROBENECIDRLDWATSON LABSANDA 084279ABApproved Prior to Jan 1, 1982
PROBEN-CWATSON LABSANDA 085552Approved Prior to Jan 1, 1982
PROBENECID AND COLCHICINEANI PHARMSANDA 083734Approved Prior to Jan 1, 1982
PROBENECID AND COLCHICINEBEECHAMANDA 084321Approved Prior to Jan 1, 1982
PROBENECID AND COLCHICINEIMPAX LABSANDA 083720Approved Prior to Jan 1, 1982
PROBENECID AND COLCHICINESANDOZANDA 086130Approved Prior to Jan 1, 1982
PROBENECID W/ COLCHICINELEDERLEANDA 086954Approved Prior to Jan 1, 1982
PROBENECID W/ COLCHICINEWATSON LABSANDA 083221Approved Prior to Jan 1, 1982

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Colchicine; probenecid — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.